Allogene Therapeutics Inc
XNAS: ALLO
Allogene Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-c...
Read More
2.50
0.20
(8.70%)
5.6M
XNAS Volume
XNAS 09 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Allogene Therapeutics Inc is on 13 Mar 2026 for the purpose of Allogene Therapeutics Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
Allogene Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..